Biotricity announced the filing of a patent application for its Biotres device. This patent protects Biotres’ proprietary 3 channel technology, multiple sensors, architecture and compact form factor, a combination that has never been done before. Up until now, compact devices have lacked multiple channels, reducing the quality of diagnosis. Biotres is an invention that marks a significant advancement in remote patient monitoring and cardiac care. This filing expands the Company’s IP portfolio while increasing market barriers.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BTCY: